Level B· Emerging clinical evidence with positive signalsRandomized Controlled TrialEurope PMCOpen access

Effectiveness of injected versus topically applied platelet-rich plasma in diabetic foot ulcers: A randomized controlled trial with clinical and histopathological assessment

Nasr M., El-Nawasany MA., Ali HE., El Nagar AE., Elsharawy AF., Mirdad DSA.

Randomized Controlled Trial with a reported sample of 20 on Diabetic Foot, Chronic Wound, published in JPRAS Open (2025) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Randomized Controlled Trial
Journal
JPRAS Open (2025)
Reported sample size
20
Source database
Europe PMC
PMID
40909759
PMCID
PMC12405637
DOI
10.1016/j.jpra.2025.08.008
Citations
2

Abstract (original English)

Background Diabetic foot ulcers (DFUs) are a serious complication of diabetes that can lead to significant morbidity. Autologous platelet-rich plasma (PRP), rich in growth factors and cytokines, has emerged as a promising treatment to enhance ulcer healing. This study aimed to compare the clinical and histological efficacy of injected PRP versus topically applied PRP and traditional wound care in the management of DFUs. Methods Sixty patients with DFUs were randomly assigned to three equal groups ( n = 20 each). Group A received locally injected autologous PRP; Group B received topically applied autologous PRP; and Group C received standard wound care. All patients were followed twice weekly for 12 weeks or until complete healing. Skin biopsies were obtained at baseline and after 12 weeks (or upon completion for unhealed ulcers) for histopathological evaluation. Results By the end of the 12-week follow-up, 87.5 % of patients treated with PRP (35 out of 40 in Groups A and B) achieved complete ulcer healing, compared to a significantly lower healing rate in the traditional care group (Group C). Histological findings supported the clinical outcomes. No significant difference was found between injected and topically applied PRP in terms of clinical effectiveness. Conclusion: PRP treatment, whether injected or topically applied, significantly enhances the healing of DFUs compared to

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research